Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

202 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Clinical Features and Outcome of Multidrug-Resistant Osteoarticular Tuberculosis: A 12-Year Case Series from France.
Bonnet I, Haddad E, Guglielmetti L, Bémer P, Bernard L, Bourgoin A, Brault R, Catho G, Caumes E, Escaut L, Fourniols E, Fréchet-Jachym M, Gaudart A, Guillot H, Lafon-Desmurs B, Lanoix JP, Lanotte P, Lemaignen A, Lemaire B, Lemaitre N, Michau C, Morand P, Mougari F, Marigot-Outtandy D, Patrat-Delon S, Perpoint T, Piau C, Pourcher V, Zarrouk V, Zeller V, Veziris N, Jauréguiberry S, Aubry A; CRIOAC Pitié-Salpêtrière and the TB Consilium of the National Reference Center for Mycobacteria. Bonnet I, et al. Among authors: perpoint t. Microorganisms. 2022 Jun 14;10(6):1215. doi: 10.3390/microorganisms10061215. Microorganisms. 2022. PMID: 35744731 Free PMC article.
Encephalitis due to Mycobacterium tuberculosis in France.
Honnorat E, De Broucker T, Mailles A, Stahl JP; le comité de pilotage et groupe des investigateurs. Honnorat E, et al. Med Mal Infect. 2013 Jun;43(6):230-8. doi: 10.1016/j.medmal.2013.05.003. Epub 2013 Jun 28. Med Mal Infect. 2013. PMID: 23816146
Management of emerging multidrug-resistant tuberculosis in a low-prevalence setting.
Catho G, Couraud S, Grard S, Bouaziz A, Sénéchal A, Valour F, Perpoint T, Braun E, Biron F, Ferry T, Chidiac C, Freymond N, Perrot E, Souquet PJ, Maury JM, Tronc F, Veziris N, Lina G, Dumitrescu O, Ader F; Lyon TB Study Group. Catho G, et al. Among authors: perpoint t. Clin Microbiol Infect. 2015 May;21(5):472.e7-10. doi: 10.1016/j.cmi.2014.12.022. Epub 2015 Jan 20. Clin Microbiol Infect. 2015. PMID: 25708551 Free article.
[Children exposed to multidrug-resistant tuberculosis: How should we manage? Analysis of 46 child contacts and review of the literature].
Catho G, Sénéchal A, Ronnaux-Baron AS, Valour F, Perpoint T, Bouaziz A, Dumitriescu O, Reix P, Pedone C, Ader F; Lyon TB Study Group. Catho G, et al. Among authors: perpoint t. Rev Pneumol Clin. 2015 Dec;71(6):335-41. doi: 10.1016/j.pneumo.2015.05.003. Epub 2015 Jul 17. Rev Pneumol Clin. 2015. PMID: 26195117 Review. French.
Linezolid in the Starter Combination for Multidrug-Resistant Tuberculosis: Time to Move on to Group Four?
Grard S, Catho G, Valour F, Bouaziz A, Perpoint T, Braun E, Biron F, Miailhes P, Ferry T, Chidiac C, Souquet PJ, Couraud S, Lina G, Goutelle S, Veziris N, Dumitrescu O, Ader F. Grard S, et al. Among authors: perpoint t. Open Forum Infect Dis. 2015 Dec 22;2(4):ofv175. doi: 10.1093/ofid/ofv175. eCollection 2015 Dec. Open Forum Infect Dis. 2015. PMID: 26719846 Free PMC article.
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trial.
Ader F, Bouscambert-Duchamp M, Hites M, Peiffer-Smadja N, Poissy J, Belhadi D, Diallo A, Lê MP, Peytavin G, Staub T, Greil R, Guedj J, Paiva JA, Costagliola D, Yazdanpanah Y, Burdet C, Mentré F; DisCoVeRy Study Group. Ader F, et al. Lancet Infect Dis. 2022 Feb;22(2):209-221. doi: 10.1016/S1473-3099(21)00485-0. Epub 2021 Sep 14. Lancet Infect Dis. 2022. PMID: 34534511 Free PMC article. Clinical Trial.
Cardiac Adverse Events and Remdesivir in Hospitalized Patients with Coronavirus Disease 2019 (COVID-19): A Post Hoc Safety Analysis of the Randomized DisCoVeRy Trial.
Terzić V, Miantezila Basilua J, Billard N, de Gastines L, Belhadi D, Fougerou-Leurent C, Peiffer-Smadja N, Mercier N, Delmas C, Ferrane A, Dechanet A, Poissy J, Espérou H, Ader F, Hites M, Andrejak C, Greil R, Paiva JA, Staub T, Tacconelli E, Burdet C, Costagliola D, Mentré F, Yazdanpanah Y, Diallo A; DisCoVeRy study group. Terzić V, et al. Clin Infect Dis. 2024 Mar 29:ciae170. doi: 10.1093/cid/ciae170. Online ahead of print. Clin Infect Dis. 2024. PMID: 38552208
202 results